Detalhe da pesquisa
1.
Targeting the Complement-Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy.
Int J Mol Sci
; 23(22)2022 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430817